NYSE:LLY - Eli Lilly And Co Stock Price, Forecast & News

Eli Lilly And Co trades on the New York Stock Exchange (NYSE) under the ticker symbol "LLY."

Eli Lilly And Co announced a quarterly dividend on Monday, December 16th. Investors of record on Friday, February 14th will be given a dividend of $0.74 per share on Tuesday, March 10th. This represents a $2.96 dividend on an annualized basis and a dividend yield of 2.12%. The ex-dividend date is Thursday, February 13th. This is an increase from Eli Lilly And Co's previous quarterly dividend of $0.65. View Eli Lilly And Co's Dividend History.

Eli Lilly And Co (NYSE:LLY) posted its earnings results on Wednesday, October, 23rd. The company reported $1.48 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.43 by $0.05. The business earned $5.48 billion during the quarter, compared to analysts' expectations of $5.50 billion. Eli Lilly And Co had a net margin of 35.10% and a return on equity of 107.99%. Eli Lilly And Co's revenue for the quarter was up 3.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.39 EPS. View Eli Lilly And Co's Earnings History.

Eli Lilly And Co is scheduled to release their next quarterly earnings announcement on Thursday, January 30th 2020. View Earnings Estimates for Eli Lilly And Co.

Eli Lilly And Co will be holding an earnings conference call on Thursday, January 30th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Eli Lilly And Co updated its FY20 earnings guidance on Tuesday, December, 17th. The company provided earnings per share guidance of $6.70-6.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.57. The company issued revenue guidance of $23.6-24.1 billion, compared to the consensus revenue estimate of $23.46 billion.

13 brokers have issued twelve-month price targets for Eli Lilly And Co's shares. Their forecasts range from $117.49 to $165.00. On average, they expect Eli Lilly And Co's share price to reach $136.18 in the next twelve months. This suggests that the stock has a possible downside of 2.4%. View Analyst Price Targets for Eli Lilly And Co.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eli Lilly And Co in the last year. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Eli Lilly And Co.

Media stories about LLY stock have trended somewhat negative on Sunday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Eli Lilly And Co earned a news sentiment score of -1.7 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Eli Lilly And Co.

Eli Lilly And Co saw a increase in short interest in December. As of December 13th, there was short interest totalling 11,580,000 shares, an increase of 9.8% from the November 28th total of 10,550,000 shares. Based on an average trading volume of 3,280,000 shares, the days-to-cover ratio is currently 3.5 days. Currently, 1.4% of the company's shares are short sold. View Eli Lilly And Co's Current Options Chain.

Some companies that are related to Eli Lilly And Co include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Allergan (AGN), Mylan (MYL), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Horizon Therapeutics (HZNP), The Medicines (MDCO), Nektar Therapeutics (NKTR), Zogenix (ZGNX) and Pacira Biosciences (PCRX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Eli Lilly And Co investors own include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), AT&T (T), Intel (INTC), JPMorgan Chase & Co. (JPM), Verizon Communications (VZ), Bank of America (BAC), Bristol-Myers Squibb (BMY) and Cisco Systems (CSCO).

Eli Lilly And Co's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Lilly Endowment Inc. (11.93%), OLD National Bancorp IN (0.07%), PGGM Investments (0.06%), Gateway Investment Advisers LLC (0.05%), Nisa Investment Advisors LLC (0.04%) and Hexavest Inc. (0.04%). Company insiders that own Eli Lilly And Co stock include Aarti S Shah, Alfonso G Zulueta, Anne E White, Christi Shaw, Daniel Skovronsky, David A Ricks, Donald A Zakrowski, Eli & Co Lilly, Enrique A Conterno, Jackson P Tai, Jeffrey N Simmons, Joshua L Smiley, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill, Stephen F Fry and Susan Mahony. View Institutional Ownership Trends for Eli Lilly And Co.

LLY stock was sold by a variety of institutional investors in the last quarter, including Lilly Endowment Inc., Assenagon Asset Management S.A., Commerzbank Aktiengesellschaft FI, DNB Asset Management AS, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Rhenman & Partners Asset Management AB, State of Alaska Department of Revenue and TIAA FSB. Company insiders that have sold Eli Lilly And Co company stock in the last year include Aarti S Shah, Alfonso G Zulueta, Christi Shaw, Donald A Zakrowski, Enrique A Conterno, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill and Stephen F Fry. View Insider Buying and Selling for Eli Lilly And Co.

LLY stock was bought by a variety of institutional investors in the last quarter, including PGGM Investments, Hexavest Inc., Centre Asset Management LLC, 6 Meridian, United Services Automobile Association, Donaldson Capital Management LLC, Country Trust Bank and Red Spruce Capital LLC. Company insiders that have bought Eli Lilly And Co stock in the last two years include Anne E White, Daniel Skovronsky, David A Ricks, Jackson P Tai and Joshua L Smiley. View Insider Buying and Selling for Eli Lilly And Co.

Shares of LLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LLY stock can currently be purchased for approximately $139.58.

Eli Lilly And Co has a market capitalization of $134.01 billion and generates $24.56 billion in revenue each year. The company earns $3.23 billion in net income (profit) each year or $5.55 on an earnings per share basis. Eli Lilly And Co employs 38,680 workers across the globe.View Additional Information About Eli Lilly And Co.

The official website for Eli Lilly And Co is http://www.lilly.com/.

Eli Lilly And Co's mailing address is LILLY CORPORATE CENTER, INDIANAPOLIS IN, 46285. The company can be reached via phone at 317-276-2000 or via email at [email protected]